World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03114761
Date of registration: 11/04/2017
Prospective Registration: No
Primary sponsor: Rijnstate Hospital
Public title: CTA for Internal Herniation After RYGB Surgery CTA-IH
Scientific title: Abdominal CT Angiography of Mesenteric Vessels for Diagnosing Internal Herniation After Roux-en-Y Gastric Bypass Surgery
Date of first enrolment: September 5, 2016
Target sample size: 12
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03114761
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Netherlands
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- The patient should have underwent laparoscopic RYGB surgery (standard procedure with
closing of mesenteric openings) at least half a year earlier;

- The patient should have abdominal pain, at least three days in a row;

- The patient should be highly suspected for internal herniation by their doctor (based
on weight loss, location of pain, intervals between pain, relation to food intake).

Exclusion Criteria:

- The patient has an age below 18;

- The patient is incompetent to decide;

- The patient is pregnant or gives breast feeding;

- The patient is in emergency setting and requires imminent surgery;

- The patient has other known abdominal pathology or prior large abdominal surgery;

- The patient has had surgery for internal herniation previously;

- The patient has had earlier surgery involving the RYGB, such as distalisation;

- One or both scans have insufficient scan quality;

- The patient will not be subjected to diagnostic laparoscopic surgery (e.g. pain-free
patients);

- The patient has a contra-indication for the administration of oral or IV contrast
(Xenetide 300mg/ml).:

- Thyrotoxicose

- Overgevoeligheid/allergisch voor Xenetix of in het verleden een allergische
reactie op jodiumhoudend contrast

- Treatment with NSAID's, diuretica or aminoglycosiden that cannot be stopped 24
hours before and after the CT

- Treatment with cisplatina less than six weeks before CT

- M.Kahler or M. Waldenstrom

- Kidneyfunction (GFS) < 60



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Internal Hernia
Intervention(s)
Radiation: CT angiography
Primary Outcome(s)
CTA examination [Time Frame: 1 year]
Secondary Outcome(s)
Standard CT examination [Time Frame: 1 year]
Secondary ID(s)
NL52257.091.15
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history